[go: up one dir, main page]

DK2183597T3 - Immunogene streptococcusproteiner - Google Patents

Immunogene streptococcusproteiner

Info

Publication number
DK2183597T3
DK2183597T3 DK08793829.6T DK08793829T DK2183597T3 DK 2183597 T3 DK2183597 T3 DK 2183597T3 DK 08793829 T DK08793829 T DK 08793829T DK 2183597 T3 DK2183597 T3 DK 2183597T3
Authority
DK
Denmark
Prior art keywords
streptococcus proteins
immunogenic streptococcus
immunogenic
proteins
streptococcus
Prior art date
Application number
DK08793829.6T
Other languages
English (en)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK2183597T3 publication Critical patent/DK2183597T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
DK08793829.6T 2007-08-06 2008-08-05 Immunogene streptococcusproteiner DK2183597T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins
PCT/NL2008/050537 WO2009020391A1 (en) 2007-08-06 2008-08-05 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
DK2183597T3 true DK2183597T3 (da) 2013-10-14

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08793829.6T DK2183597T3 (da) 2007-08-06 2008-08-05 Immunogene streptococcusproteiner

Country Status (19)

Country Link
US (1) US20100297183A1 (da)
EP (3) EP2023143A1 (da)
JP (2) JP5462164B2 (da)
KR (1) KR20100063706A (da)
CN (1) CN101821627A (da)
AR (1) AR067830A1 (da)
AU (1) AU2008284491A1 (da)
BR (1) BRPI0815604A2 (da)
CA (1) CA2695721A1 (da)
CL (1) CL2008002320A1 (da)
CO (1) CO6270172A2 (da)
DK (1) DK2183597T3 (da)
ES (1) ES2432407T3 (da)
MX (1) MX2010001482A (da)
RU (1) RU2518315C2 (da)
TW (1) TW200911999A (da)
UA (1) UA103885C2 (da)
WO (1) WO2009020391A1 (da)
ZA (1) ZA201000806B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL204863B1 (pl) * 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
CA2436530C (en) 2001-02-02 2013-10-01 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes of streptococcus suis
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
WO2015042423A2 (en) * 2013-09-19 2015-03-26 Zoetis Llc Vaccine
CN107108756A (zh) * 2014-12-22 2017-08-29 豪夫迈·罗氏有限公司 细胞穿透性肽
US11325950B2 (en) 2015-10-21 2022-05-10 Minervax Aps Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
IL301666A (en) * 2020-12-23 2023-05-01 Chan Zuckerberg Biohub Inc Bacteria-engineered to produce antigen-specific T cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用
CN119780429A (zh) * 2024-12-27 2025-04-08 华派生物技术(集团)股份有限公司 一种提高猪圆环病毒2型Cap蛋白抗原琼扩检测灵敏度的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
AU2638595A (en) * 1994-05-16 1995-12-05 Uab Research Foundation, The (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
DK0900380T3 (da) 1996-04-26 2003-11-03 Seed Capital Investments Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
PL204863B1 (pl) * 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
DK1140157T3 (da) * 1998-12-21 2009-06-08 Medimmune Inc Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
DK1409654T3 (da) * 1999-06-16 2008-12-08 Boston Biomedical Res Inst Immunologisk styring af beta-amyloid-niveauer in vivo
DE60136356D1 (de) * 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
CA2436530C (en) * 2001-02-02 2013-10-01 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes of streptococcus suis
US7517955B2 (en) * 2002-11-26 2009-04-14 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
WO2004067559A1 (en) * 2003-01-27 2004-08-12 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
EP2327720A1 (en) * 2003-05-30 2011-06-01 Intercell AG Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
EP2505209A1 (en) * 2006-06-26 2012-10-03 MacroGenics, Inc. Fcgamma-RIIB-specific antibodies and methods of the use thereof

Also Published As

Publication number Publication date
EP2023143A1 (en) 2009-02-11
CL2008002320A1 (es) 2009-09-25
JP5462164B2 (ja) 2014-04-02
KR20100063706A (ko) 2010-06-11
CN101821627A (zh) 2010-09-01
US20100297183A1 (en) 2010-11-25
RU2518315C2 (ru) 2014-06-10
CA2695721A1 (en) 2009-02-12
EP2183597B1 (en) 2013-07-24
ZA201000806B (en) 2010-10-27
EP2660604A2 (en) 2013-11-06
EP2660604A3 (en) 2014-02-12
WO2009020391A1 (en) 2009-02-12
MX2010001482A (es) 2010-03-01
AU2008284491A1 (en) 2009-02-12
CO6270172A2 (es) 2011-04-20
AR067830A1 (es) 2009-10-21
BRPI0815604A2 (pt) 2015-03-03
ES2432407T3 (es) 2013-12-03
UA103885C2 (en) 2013-12-10
TW200911999A (en) 2009-03-16
RU2010107878A (ru) 2011-09-20
JP2014095721A (ja) 2014-05-22
JP2010535500A (ja) 2010-11-25
EP2183597A1 (en) 2010-05-12

Similar Documents

Publication Publication Date Title
DK2183597T3 (da) Immunogene streptococcusproteiner
DK3118221T3 (da) Proteiner
ATE462444T1 (de) Immunogene zusammensetzung
SI2126093T1 (sl) Izboljšanje priprave proteinov
EP2215246A4 (en) PROTEIN SCAFFOLDS
EP2406399A4 (en) MIRAC PROTEINS
HRP20170963T1 (hr) Modificirani saharidi
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
EP2180160A4 (en) TURBOCHARGER
LT2411048T (lt) Adjuvantinį meningokokinį faktorių h surišantis baltymas
DK2114993T3 (da) Vaccine
EP2226484A4 (en) TURBOCHARGER
BRPI0816771A2 (pt) Espaçador interespinhal
DK2200646T3 (da) RNA-Vacciner
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
ATE544614T1 (de) Vorimprägnat
BRPI0814971A2 (pt) Proteína
DK2132326T3 (da) Fremgangsmåder
DK2125048T3 (da) Præparat
PL2158387T3 (pl) Układ sprężarki
EP2402032A4 (en) IMMUNOGENIC COMPOSITION
BRPI1007934A2 (pt) "dabigatrana liofilizada"
BRPI0809678A2 (pt) Métodos
DK2133416T3 (da) Rekombinant mikroorganisme
FI20075144L (fi) Intubaatioapuväline